Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics
| Image |  |
|---|---|
| Description | article published in 2011 |
| Author/s |
author: Claudia Haferlach Susanne Schnittger Torsten Haferlach |
| Publication date | April 15, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |